Showing results (51-60 of 118) with videos related to
Sort By:
Pageof 12
Blood|October 1, 1990
Characterization of a factor-dependent acute leukemia cell line with translocation (3;3)(q21;q26)J Oval, O W Jones, M Montoya, et al.Blood|October 1, 1983
Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytesD A Carson, D B Wasson, R Taetle, et al.Experimental Hematology|March 1, 1991
Analysis of granulocyte-macrophage colony-stimulating factor action in differentiating myeloid leukemia cells: treatment with DMSO may reveal a common pathway for growth factor gene regulationR Taetle, J Oval, M Smedsrud, et al.Journal of Cellular Physiology|September 1, 1987
Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cellsJ Castagnola, C MacLeod, H Sunada, et al.Cancer Treatment Reports|March 1, 1987
Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenograftsR Taetle, F Rosen, I Abramson, et al.The Journal of Clinical Investigation|March 1, 1985
Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibodyR Taetle, K Rhyner, J Castagnola, et al.Cancer Genetics and Cytogenetics|May 29, 1999
Frequent alterations of evolutionarily conserved regions of chromosome 1 in human malignant melanomaJ Zhang, A A Glatfelter, R Taetle, et al.Leukemia Research|January 1, 1982
Colony-forming assay for circulating chronic lymphocytic leukemia cellsR Taetle, D Richardson, D To, et al.Leukemia Research|February 5, 1999
Limited erythropoietic response to combined treatment with recombinant human interleukin 3 and erythropoietin in myelodysplastic syndromeA M Miller, W E Noyes, R Taetle, et al.Leukemia Research|May 19, 1998
Treatment with low-dose oral etoposide in patients with myelodysplastic syndromesD C Doll, L M Kasper, R Taetle, et al.Pageof 12